A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma.
Richardson, Paul G.; Barlogie, Bart; Berenson, James; Singhal, Seema; Jagannath, Sundar; Irwin, David; Rajkumar, S. Vincent; Srkalovic, Gordan; Alsina, Melissa; Alexanian, Raymond; Siegel, David; Orlowski, Robert Z.; Kuter, David; Limentani, Steven A.; Lee, Stephanie; Hideshima, Teru; Esseltine, Dixie-Lee; Kauffman, Michael; Adams, Julian; Schenkein, David P.; New England Journal of Medicine, 2003, vol. 348, issue 26, p 2609, ISSN 00284793. ISBN 00284793.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef